Alimta
Links shared publicly online about this topic
UK backs funding for Lilly's Alimta in lung cancer
us.mobile.reuters.com — “UK backs funding for Lilly's Alimta in lung cancer” View full resource at us.mobile.reuters.com
Most Recently Shared on August 6, 2009 at 3:46 pm By:
RT @blogaceutics: UK backs funding for Lilly's Alimta in lung cancer [Reuters] http://bit.ly/Uk8tH
UK NICE recommends Eli Lilly's ALIMTA as maintenance therapy for nonsquamous NSCLC
news-medical.net — “Eli Lilly and Company announced today that its chemotherapy ALIMTA® (pemetrexed for injection) received a positive "Final Appraisal Determination" from the United Kingdom's National Institute for Health and Clinical Excellence (NICE).” View full resource at news-medical.net
Most Recently Shared on April 2, 2010 at 6:15 am By:
Pregnancy News: UK NICE recommends Eli Lilly's ALIMTA as maintenance therapy for nonsquamous NSCLC: Eli Lilly and ... http://bit.ly/9aUs44
Alimta Approved as Maintenance Therapy for Advanced Lung Cancer - iVillage Your Total Health
yourtotalhealth.ivillage.com — “The drug Alimta (pemetrexed) has been approved by the U.S. Food and Drug Administration to prevent progression of certain types of advanced or metastatic (spreading) lung cancer, the agency said Monday.” View full resource at yourtotalhealth.ivillage.com
Most Recently Shared on July 6, 2009 at 6:48 pm By:
Alimta Approved as Maintenance Thera... http://bit.ly/ezfi5
Eli Lilly and Company - Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
newsroom.lilly.com — “Eli Lilly and Company - Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)” View full resource at newsroom.lilly.com
Most Recently Shared on July 6, 2009 at 2:56 pm By:
eyeonfda Pharma and Health Lawyer
ALIMTA First Chemotherapy Approved As Maintenance Therapy For Nonsquamous Non-Small Cell Lung Cancer - http://bit.ly/bN3Lz
Alimta approved for nonsquamous non-small cell lung cancer (NSCLC) maintenance therapy - MPR
empr.com — “The FDA has approved Alimta (pemetrexed injection, from Eli Lilly) as maintenance therapy for patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.” View full resource at empr.com
Most Recently Shared on July 6, 2009 at 3:50 pm By:
MPR News: Alimta approved for nonsquamous non-small cell lung cancer (NSCLC) maintenance therapy: The F.. http://tinyurl.com/mvpd5u
Eli Lilly to present results of two Phase II trials evaluating ALIMTA in combination with chemotherapy, radiation
news-medical.net — “Results of two Phase II trials evaluating ALIMTA (pemetrexed for injection) in combination with a platinum chemotherapy and radiation for patients with locally advanced non-small cell lung cancer will be presented by Eli Lilly and Company at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Ill., on June 6, 2010.” View full resource at news-medical.net
Most Recently Shared on May 21, 2010 at 3:05 pm By:
Pregnancy News: Eli Lilly to present results of two Phase II trials evaluating ALIMTA in combination with chemothe... http://bit.ly/awZWu0
Eli Lilly presents ALIMTA Phase III trial results at ESMO Annual Meeting
news-medical.net — “Eli Lilly and Company announced today that its global Phase III trial evaluating ALIMTA (pemetrexed for injection) in combination with cisplatin in patients with recurrent or metastatic squamous cell cancer of the head and neck (SCCHN) did not meet its primary endpoint for overall survival. Data were presented for the first time today at the 35th Annual Meeting of the European Society for Medical Oncology (ESMO).” View full resource at news-medical.net
Most Recently Shared on October 11, 2010 at 2:59 pm By:
Pregnancy News: Eli Lilly presents ALIMTA Phase III trial results at ESMO Annual Meeting: Eli Lilly and Company an... http://bit.ly/aBoYmt
FDA Approves Alimta As Lung-Cancer Maintenance Therapy - WSJ.com
online.wsj.com — “The FDA has given doctors the official go-ahead to continue treatment with Alimta in patients with certain types of non-small cell lung cancer, the most common form of the disease.” View full resource at online.wsj.com
Most Recently Shared on July 7, 2009 at 12:53 am By:
Chemotherapy Drug Gains New Approval http://tinyurl.com/mvhdlp
Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit
news-medical.net — “Data published today in The Lancet showed a survival benefit in nonsquamous patients with advanced non-small cell lung cancer (NSCLC) who received maintenance therapy with ALIMTA(R) (pemetrexed for injection) plus best supportive care as compared to placebo plus best supportive care.” View full resource at news-medical.net
Most Recently Shared on September 21, 2009 at 7:10 pm By:
Lung Cancer News: Study reveals that patients with NSCLC who received maintenance therapy with .. http://digg.com/u1Cs3O
Lung Cancer Study Reveals Similar Outcomes for African-American and Caucasian Patients Treated With Alimta - Drugs.com MedNews
drugs.com — “Lilly Committed to Evaluating Medicines in Diverse Populations INDIANAPOLIS, Sept. 20, Lung cancer, the leading cause of cancer death in the U.S., takes a parti” View full resource at drugs.com
Most Recently Shared on September 20, 2011 at 3:09 pm By:
Drugs and Devices OW OW Health
Lung Cancer Study Reveals Similar Outcomes for African-American and Caucasian Patients Treated With Alimta... http://t.co/D6OCctRR #drug
Alimta 100mg/500mg powder for concentrate for solution for infusion - Revised SPC - NeLM [2.1.9]
nelm.nhs.uk — “Alimta 100mg/500mg powder for concentrate for solution for infusion - Revised SPC - NeLM [2.1.9]” View full resource at nelm.nhs.uk
Most Recently Shared on February 23, 2011 at 8:18 am By:
Alimta 100mg/500mg powder for concentrate for solution for infusion - Revised SPC: Source: eMC (electronic Medic... http://bit.ly/gAsEWh
Eli Lilly and Company - ALIMTA(R) (pemetrexed for injection) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer
newsroom.lilly.com — “Eli Lilly and Company - ALIMTA(R) (pemetrexed for injection) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer” View full resource at newsroom.lilly.com
Most Recently Shared on July 10, 2009 at 5:45 pm By:
eyeonfda Pharma and Health Lawyer
ALIMTA(R) (pemetrexed for injection) 1st Approval in EUas Maintenance Therapy for Adv Nonsquamous NSC Lung Cancer http://bit.ly/rwSmS
Eli Lilly and Company - ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer
newsroom.lilly.com — “Eli Lilly and Company - ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer” View full resource at newsroom.lilly.com
Most Recently Shared on May 29, 2009 at 6:07 pm By:
eyeonfda Pharma and Health Lawyer
ALIMTA(R) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer - http://bit.ly/SGd4i
Eli Lilly and Company - ALIMTA(R) Recommended by Special Health Authority in United Kingdom as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer
newsroom.lilly.com — “Eli Lilly and Company - ALIMTA(R) Recommended by Special Health Authority in United Kingdom as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer” View full resource at newsroom.lilly.com
Most Recently Shared on April 1, 2010 at 4:05 pm By:
eyeonfda Pharma and Health Lawyer
ALIMTA(R) Reco'd in UK as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer - http://ow.ly/1tEZM
Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing... | Reuters
reuters.com — “Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer Study Evaluated Lilly's ALIMTA(R) (pemetrexed for injection) versus Placebo as Maintenance” View full resource at reuters.com
Most Recently Shared on September 21, 2009 at 3:15 pm By:
Study Published in The Lancet Showed Significant Survival Benefit ... http://bit.ly/1qwlhO
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Silja
Passionately believe pharma can create better patient-focus through social media Co-founder of #hcsmeu Healthcare and Social media in Europe tweet up
-
News-Medical.Net
Stay up to date with the latest Pregnancy news and research via News-Medical.Net
-
Your Total Health
top health news information and healthy living tips
Advertisement
